secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sanara MedTech Inc. (SMTI)
CIK:        0000714256
Form:       8-K
Filed at:   2024-09-11T23:59:59+00:00
Accession:  0001493152-24-035783
Event type: m_and_a
Sentiment:  positive
Materiality: 0.70
Item codes: 7.01, 8.01, 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sanara invests $5M for 6.6% of ChemoMouthpiece, exclusive U.S. distribution via InfuSystem JV
--------------------------------------------------------------------------------

- Sanara CMP purchased 100,674.72 common units in ChemoMouthpiece for $5.0 million, a 6.64% ownership stake.
- SI Technologies (50/50 JV with InfuSystem) appointed sole U.S. distributor of ChemoMouthpiece kits for 5 years.
- SI Technologies has an option to purchase ChemoMouthpiece's U.S. business, including IP, expiring Jan 31, 2029.
- Sanara borrowed an additional $15.5M under its CRG term loan at 13.25% per annum, maturing May 30, 2029.
- Proceeds used for the ChemoMouthpiece investment; remaining funds for acquisitions and working capital.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/714256/000149315224035783/0001493152-24-035783-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/714256/000149315224035783/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-035783

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer